Related Articles
Lenvatinib vs. palliative therapy for stage IVC anaplastic thyroid cancer
Lenvatinib as a novel treatment for anaplastic thyroid cancer: A retrospective study
Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo
Relationship between adverse events associated with lenvatinib treatment for thyroid cancer and patient prognosis
Non‑invasive monitoring of paclitaxel and lenvatinib efficacy against anaplastic thyroid cancer in orthotopic SCID mouse models using small‑animal FDG‑PET/CT